Federal Data Hub › HRSA 340B · JSON

Michael Reese Research and Education Foundation

HIV Care Program · 340B ID RWI60616

ParticipatingRWI

Michael Reese Research and Education Foundation is a RWI enrolled in the federal 340B Drug Pricing Program in Chicago, IL. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 13 contract-pharmacy arrangement(s) (12 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (13)

PharmacyLocationBeginTerminatedPharmacy ID
APOTHECARE, INC.CHICAGO, IL2011-10-01—2967
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2013-10-01—3396
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2026-07-01—7888
BOND DRUG COMPANY OF ILLINOIS, L.L.C.CHICAGO, IL2023-04-01—1641
WALGREEN CO.CHICAGO, IL2024-04-01—108800
WALGREEN CO.CHICAGO, IL2026-07-01—3365
WALGREEN CO.CHICAGO, IL2026-07-01—7630
WALGREEN CO.CHICAGO, IL2026-07-01—3368
WALGREEN CO.CHICAGO, IL2026-07-01—87379
WALGREEN CO.CHICAGO, IL2023-04-01—4984
WALGREEN CO.CHICAGO, IL2020-07-012026-05-20107300
WALGREEN CO.GLENVIEW, IL2024-04-01—8074
Walgreen COBolingbrook, IL2025-07-01—136147

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.